Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Watson Files Application for Generic FEMCON(R) Fe
October 03, 2007
- Paragraph IV Patent Challenge Underway - Read More
from PR Newswire
Watson Receives FDA Approval for Generic Accuneb(R)
September 26, 2007
from PR Newswire
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
September 25, 2007
from Business Wire News Releases
Generic Drugmaker Watson Pharma Expands Asian Operations as it Consolidates in U.S., an Industrial Info News Alert
September 06, 2007
from Marketwired News Releases
Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
September 04, 2007
from PR Newswire
Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
September 04, 2007
from PR Newswire
Watson Receives FDA Approval For Generic Duragesic(R)
August 21, 2007
from PR Newswire
Watson Announces CEO Succession Plan
August 02, 2007
- Allen Chao, Ph.D., to Retire as CEO - Read More
from PR Newswire
Watson Pharmaceuticals Reports Second Quarter 2007 Results
August 02, 2007
- Company Reports Total Net Revenue of $603 Million - Read More
from PR Newswire
Abraxis BioScience Acquires Manufacturing Facility from Watson
July 31, 2007
from Business Wire News Releases
Depomed Enters into Promotion Agreement with Watson for ProQuin(R) XR
July 23, 2007
from Business Wire News Releases
Watson to Host Second Quarter 2007 Earnings Conference Call and Webcast
July 23, 2007
from PR Newswire
Watson Receives FDA Final Approval for Generic Wellbutrin XL(R) 300 Mg
June 13, 2007
from PR Newswire
Watson to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
June 05, 2007
from PR Newswire
Watson Pharmaceuticals to Present at the Bank of America 2007 Health Care Conference
May 23, 2007
from PR Newswire
Watson Enters Into Agreement to Permit Sandoz to Launch Metoprolol Succinate Extended-Release 50 mg Tablets; Relinquishes 180-Day Market Exclusivity
May 21, 2007
from PR Newswire
Watson Pharmaceuticals Reports First Quarter 2007 Results
May 01, 2007
- Company Reports Total Net Revenue of $672 Million - Read More
from PR Newswire
Watson Pharmaceuticals to Webcast Its 2007 Annual Meeting of Stockholders
April 27, 2007
from PR Newswire
Watson to Host First Quarter 2007 Earnings Conference Call and Webcast
April 25, 2007
from PR Newswire
HealthShares(TM) Announces Change to the HealthShares(TM) Ophthalmology Index
April 09, 2007
from PR Newswire
Watson Pharmaceuticals to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
April 09, 2007
from PR Newswire
Watson Pharmaceuticals to Present at the Lehman Brothers Tenth Annual Global Healthcare Conference
March 16, 2007
from PR Newswire
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Results
February 27, 2007
Company Reports Fourth Quarter Total Net Revenue of $621 Million; Read More
from PR Newswire
Watson and GlaxoSmithKline Settle Lawsuit Over Wellbutrin Xl(R)
February 12, 2007
from PR Newswire
Watson to Host Fourth Quarter and Full Year 2006 Earnings Conference Call and Webcast
February 01, 2007
from PR Newswire
Warner Chilcott and Watson Pharmaceuticals Announce Launch of Zenchent(TM)
January 29, 2007
from PR Newswire
Wall Street News Alert: Stocks on the Move for Tuesday! January 16, 2007
January 16, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
January 16, 2007
- Statistical Significance Reached on Primary and Secondary Endpoints - Read More
from PR Newswire
Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
January 05, 2007
from Business Wire News Releases
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
December 29, 2006
from Business Wire News Releases
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here